BRISTOL, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has just released its extensive report on the "Glycopeptide Antibiotics Market" which details the industry's past, present, and future in terms of both products and marketing. The objective of winning the Glycopeptide Antibiotics market report is to provide a detailed analysis of the Glycopeptide Antibiotics industry and its impact based on applications and on different geographical regions, strategically analyzing the growth trends and future prospects. By keeping in mind the way people live, believe, and expend, market research analysis has been carried out to provide quality market insights. The company profiles of all the key players and brands that are dominating the Glycopeptide Antibiotics market with moves like product launches, joint ventures, mergers, and acquisitions which in turn is affecting the sales, import, export, revenue, and CAGR values are mentioned in the finest Glycopeptide Antibiotics report.
Data Bridge Market Research analyses a growth rate in the glycopeptide antibiotics market in the forecast period 2023-2030. The expected CAGR of glycopeptide antibiotics market tends to be around 10% in the mentioned forecast period. The market was valued at USD 3.07 billion in 2022, and it would grow up to USD 6.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Grab a PDF Sample of the Glycopeptide Antibiotics Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-glycopeptide-antibiotics-market
Market Definition:
Glycopeptide antibiotics are the kind of antibiotic which obstructs bacterial cell wall formation by restricting peptidoglycan synthesis. They are widely used for the treatment of multi-resistant Staphylococcus aureus (MRSA) infections and other enterococcal infections, which are unaffected to beta-lactams and other antibiotics. They are also used in cases where there is an allergy to beta-lactams.
Growing incidence of cancer and other infectious diseases are anticipated to increase the growth during the forecast period. The common glycopeptides that are currently used in clinical practice to treat enterococcal infections are teicoplanin and vancomycin. The growth of glycopeptide antibiotics market is increased by the growing cases of numerous infectious diseases and emerging launches in research and development activities that are conducted by many pharmaceuticals’ companies.
Fundamental Aim of Glycopeptide Antibiotics Market Report
In the Glycopeptide Antibiotics market, every company has goals, but this report focus in on the most important ones, allowing you to gain insight into the competition, the future of the market, potential new products, and other useful information that can boost your sales significantly.
- Factors influencing the Glycopeptide Antibiotics Market Size and growth rate.
- Major alterations to the Glycopeptide Antibiotics Market in the near future.
- Notable Market rivals around the world.
- The Glycopeptide Antibiotics Market's Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
- Sales data and profiles of the world's leading Glycopeptide Antibiotics manufacturers
The Glycopeptide Antibiotics Market is Dominated by Firms Such as
- ANI Pharmaceuticals, Inc. (U.S.)
- Fresenius SE & Co. KGaA (Germany)
- Pfizer Inc (U.S.)
- Mylan N.V. (U.S.)
- Novartis AG (U.S.),
- Hikma Pharmaceuticals plc (U.K.)
- Aurobindo Pharma (India)
- Abbvie, Inc (U.S.)
- Melinta Therapeutics, Inc (U.S.)
- Cumberland Pharmaceuticals Inc (U.S.)
- Theravance Biopharma (U.S.)
- Janssen Global Services, LLC (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- GSK plc. (U.K.)
- Bayer AG (U.S.)
Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-glycopeptide-antibiotics-market
The investment made in the study would provide you access to information such as:
- Glycopeptide Antibiotics Industry [Global – Broken-down into regions]
- Regional level split [North America, Europe, Asia Pacific, South America, Middle East & Africa]
- Country wise Market Size Split [of important countries with major market share]
- Market Share and Revenue/Sales by leading players
- Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, etc.
- Market Size
- Market Size by application/industry verticals
- Market Projections/Forecast
Opportunities:
- Increasing Demand for Retail Pharmacies
The increase in the number of narcotic drugs which is delivered through retail pharmacies and the rise in the number of retail pharmacies in developing and developed countries create opportunities for market growth. Additionally, patients choose retail pharmacies for purchasing drugs, as these are easily available.
- Higher Efficiency of Novel Drugs
The efficiency of several existing products is anticipated to result into increasing revenues due to doctor recommendations. For instance, BLEOMYCIN for injection USP is the mixture of cytotoxic glycopeptide antibiotics which is isolated from Streptomyces verticillus and is widely used for the treatment of testicular carcinoma, squamous cell carcinoma, and various types of lymphomas.
Key Market Segments Covered in Glycopeptide Antibiotics Industry Research
By Drugs
- Vancomycin
- Dalbavancin
- Oritavancin
By Indication
- Skin and Structure Infection
- Meningitis
- Clostridioides Difficile Infection
By Route of Administration
- Oral
- Parenteral
By End-Users
- Hospitals
- Specialty Clinics
- Homecare
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Key Growth Drivers:
- Rising Cases of Cancer and Infectious Diseases
Growing cancer and other infectious diseases are anticipated to boost the market growth during the forecast period 2023-2030. For instance, according to the CDC reports U.S, 1,752,735 new cancer cases combined with 599,589 deaths were observed in 2019. Additionally, according to the records of Globocan 2020, U.K., around 457,960 new cases with 179,648 deaths were reported in 2020. As per the reports, the most common types of malignancies observed were breast, prostate cancer and Non-Hodgkin’s lymphoma. Thus, this growing incidence is demanding higher rate of antibiotics and thus boosting the market growth.
- Increased Collaborations and Acquisitions
Several collaborations associated with the glycopeptide antibiotics are increasing the market growth. For instance, AbbVie Inc got U.S. FDA approval for DALVANCE in July 2021 for the treatment of acute bacterial skin and other skin structure infections in pediatric patients since birth. Additionally, Sandoz International GmbH launched Daptomycin injection 500 mg, in the U.S. market in July 2020, for treating complicated skin and skin structure infections and numerous type of bloodstream infections. Thus, it boost the market growth.
Browse Detailed Summary of Research Report @ https://www.databridgemarketresearch.com/reports/global-glycopeptide-antibiotics-market
Glycopeptide Antibiotics Market Regional Analysis/Insights:
The major countries covered in the glycopeptide antibiotics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the market because of the increasing occurrence of asthma, and severe pain and increased drug abuse.
Asia-Pacific is considered to grow over the coming years because of the attracting attention of major market players to establish many emerging economics with significant growth.
Answers That the Report Acknowledges:
- Market size and growth rate during forecast period.
- Key factors driving the “Glycopeptide Antibiotics Market”
- Key market trends cracking up the growth of the “Glycopeptide Antibiotics Market”
- Challenges to market growth.
- Key vendors of “Glycopeptide Antibiotics Market”
- Detailed SWOT analysis.
- Opportunities and threats faces by the existing vendors in Global “Glycopeptide Antibiotics Market”
- Trending factors influencing the market in the geographical regions.
- Strategic initiatives focusing the leading vendors.
- PEST analysis of the market in the five major regions.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Glycopeptide Antibiotics Market: Regulations
- Market Overview
- Global Glycopeptide Antibiotics Market, By Drugs
- Global Glycopeptide Antibiotics Market, By Indication
- Global Glycopeptide Antibiotics Market, By Route of Administration
- Global Glycopeptide Antibiotics Market, By End User
- Global Glycopeptide Antibiotics Market, By Distribution Channel
- Global Glycopeptide Antibiotics Market, By Region
- Global Glycopeptide Antibiotics Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-glycopeptide-antibiotics-market
Explore More Reports:
- Animal Antibiotics Antimicrobials Market, By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Lincosamides, Cephalosporins), Mode of Delivery (Premixes, Oral Powder, Injection, Others), Animal Type (Food-producing Animals, Companion Animals) https://www.databridgemarketresearch.com/reports/global-animal-antibiotics-antimicrobials-market
- Macrolide Antibiotics Market, By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories) https://www.databridgemarketresearch.com/reports/global-macrolide-antibiotics-market
- Antibiotics Market, By Indication (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections and Others), Drug Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), Route of Administration (Oral, Parenteral, Topical, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy Others) https://www.databridgemarketresearch.com/reports/global-antibiotics-market
- Peptide Antibiotics Market, By Product Type (Ribosomal Synthesized Peptide Antibiotics and Non-ribosomal Synthesized Peptide Antibiotics), Drugs (Daptomycin, Dalbavancin, Telavancin, Others), Route of Administration (Oral, Parenteral, Topical, Others), Distribution Channel (Hospitals, Homecare, Specialty Clinics, Others) https://www.databridgemarketresearch.com/reports/global-peptide-antibiotics-market
- Systemic Antibiotics Market, By Drug Class (Beta Lactam & Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), Indication (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-systemic-antibiotics-market
- Topical Antibiotics Market, By Application (Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Solid Tumor, Epithelial Tumor, Others), Route of Administration (Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) https://www.databridgemarketresearch.com/reports/global-topical-antibiotics-market
- Antibiotics in Aquaculture Market, By Application (Food Safety Hazards, Environmental Issues, Bacterial infections, Animal Growth, Others), Drug Type (Ox tetracycline, Florfenicol, Sulfamerazine, Others), Mode of Administration (Oral, Immersion) https://www.databridgemarketresearch.com/reports/global-antibiotics-in-aquaculture-market
- Antibiotics in Animal Feed Market By Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Cephalosporins, And Others) Form (Pellets, Crumbles, Mash, Others), Species (Poultry, Ruminants, Swine, Aqua, Others) https://www.databridgemarketresearch.com/reports/global-antibiotics-in-animal-feed-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
